Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139492754> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2139492754 endingPage "1449" @default.
- W2139492754 startingPage "1446" @default.
- W2139492754 abstract "Study the impact of transtympanic gentamicin on patients with unilateral Meniere's syndrome. Partial chemical labyrinthectomy is a relatively recent concept for the treatment of Meniere's syndrome. It uses the ototoxic effect of gentamicin to reduce the symptom of vertigo and maintain cochlear function.A prospective study using transtympanic gentamicin was begun in January 1994. Patients selected had failed medical therapy, but were not incapacitated. Patients had preinjection audiometric and electronystagmography data. Most had an imaging study. All had one injection, about half had more than one. Patients were seen 1 month after therapy and repeat studies were obtained. Repeat injection was performed if indicated. Follow-up from the chart or by telephone was obtained. Data were tabulated using the 1995 American Academy of Otologaryngology-Head and Neck Surgery guidelines.Through December 1996 43 patients with unilateral Meniere's syndrome were treated. The pretherapy function level was 3 through 5. After therapy the function level was 1 or 2. There was almost no change in cochlear function and no patient became deaf. Many patients had mild ataxia or dysequilibrium during the first 2 weeks following therapy. Most patients showed some decrease in labyrinthine function measured on electronystagmography. No attempt was made to ablate labyrinthine function. Seventeen of 18 patients had a vertigo index in the class A or B category after 2 years.Transtympanic gentamicin has become the treatment of choice for patients who fail medical therapy for Meniere's syndrome at the authors' institution." @default.
- W2139492754 created "2016-06-24" @default.
- W2139492754 creator A5005503070 @default.
- W2139492754 creator A5057691223 @default.
- W2139492754 creator A5074343292 @default.
- W2139492754 creator A5075364771 @default.
- W2139492754 date "1998-10-01" @default.
- W2139492754 modified "2023-10-11" @default.
- W2139492754 title "Transtympanic gentamicin for meniere's syndrome" @default.
- W2139492754 cites W1971973958 @default.
- W2139492754 cites W2034861025 @default.
- W2139492754 cites W2084859291 @default.
- W2139492754 cites W2094780740 @default.
- W2139492754 cites W2128517077 @default.
- W2139492754 cites W2128941263 @default.
- W2139492754 cites W2160214975 @default.
- W2139492754 cites W2256410958 @default.
- W2139492754 cites W2407520631 @default.
- W2139492754 doi "https://doi.org/10.1097/00005537-199810000-00005" @default.
- W2139492754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9778281" @default.
- W2139492754 hasPublicationYear "1998" @default.
- W2139492754 type Work @default.
- W2139492754 sameAs 2139492754 @default.
- W2139492754 citedByCount "35" @default.
- W2139492754 countsByYear W21394927542012 @default.
- W2139492754 countsByYear W21394927542013 @default.
- W2139492754 countsByYear W21394927542017 @default.
- W2139492754 countsByYear W21394927542019 @default.
- W2139492754 countsByYear W21394927542020 @default.
- W2139492754 countsByYear W21394927542021 @default.
- W2139492754 countsByYear W21394927542022 @default.
- W2139492754 crossrefType "journal-article" @default.
- W2139492754 hasAuthorship W2139492754A5005503070 @default.
- W2139492754 hasAuthorship W2139492754A5057691223 @default.
- W2139492754 hasAuthorship W2139492754A5074343292 @default.
- W2139492754 hasAuthorship W2139492754A5075364771 @default.
- W2139492754 hasConcept C141071460 @default.
- W2139492754 hasConcept C2775832221 @default.
- W2139492754 hasConcept C2777352433 @default.
- W2139492754 hasConcept C2779135839 @default.
- W2139492754 hasConcept C2780493683 @default.
- W2139492754 hasConcept C2780554537 @default.
- W2139492754 hasConcept C2780865074 @default.
- W2139492754 hasConcept C42219234 @default.
- W2139492754 hasConcept C501593827 @default.
- W2139492754 hasConcept C548259974 @default.
- W2139492754 hasConcept C71924100 @default.
- W2139492754 hasConcept C86803240 @default.
- W2139492754 hasConcept C89423630 @default.
- W2139492754 hasConceptScore W2139492754C141071460 @default.
- W2139492754 hasConceptScore W2139492754C2775832221 @default.
- W2139492754 hasConceptScore W2139492754C2777352433 @default.
- W2139492754 hasConceptScore W2139492754C2779135839 @default.
- W2139492754 hasConceptScore W2139492754C2780493683 @default.
- W2139492754 hasConceptScore W2139492754C2780554537 @default.
- W2139492754 hasConceptScore W2139492754C2780865074 @default.
- W2139492754 hasConceptScore W2139492754C42219234 @default.
- W2139492754 hasConceptScore W2139492754C501593827 @default.
- W2139492754 hasConceptScore W2139492754C548259974 @default.
- W2139492754 hasConceptScore W2139492754C71924100 @default.
- W2139492754 hasConceptScore W2139492754C86803240 @default.
- W2139492754 hasConceptScore W2139492754C89423630 @default.
- W2139492754 hasIssue "10" @default.
- W2139492754 hasLocation W21394927541 @default.
- W2139492754 hasLocation W21394927542 @default.
- W2139492754 hasOpenAccess W2139492754 @default.
- W2139492754 hasPrimaryLocation W21394927541 @default.
- W2139492754 hasRelatedWork W2261025262 @default.
- W2139492754 hasRelatedWork W2320161281 @default.
- W2139492754 hasRelatedWork W2333304682 @default.
- W2139492754 hasRelatedWork W2395933496 @default.
- W2139492754 hasRelatedWork W2412552606 @default.
- W2139492754 hasRelatedWork W2569880051 @default.
- W2139492754 hasRelatedWork W3149978270 @default.
- W2139492754 hasRelatedWork W346799588 @default.
- W2139492754 hasRelatedWork W4232069109 @default.
- W2139492754 hasRelatedWork W4307328581 @default.
- W2139492754 hasVolume "108" @default.
- W2139492754 isParatext "false" @default.
- W2139492754 isRetracted "false" @default.
- W2139492754 magId "2139492754" @default.
- W2139492754 workType "article" @default.